About the talk
Evofem Biosciences is revolutionizing the world of birth control with their entirely hormone free product, Phexxi. CEO Saundra Pelletier discusses the future of this exciting brand.
I am honored to be the Chair and CEO of Evofem Biosciences, Inc. (NASDAQ: EVFM) — a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women’s sexual and reproductive health. In September 2020, we launched Phexxi™, the first and only hormone-free, on-demand, prescription vaginal gel approved in the United States for the prevention of pregnancy. We are also advancing Phexxi through a Phase 3 registrational trial for two potential new indications - the prevention of urogenital transmission of both chlamydia and gonorrhea in women, with top-line data expected in 2H 2022.View the profile
A dynamic achiever with an entrepreneurial, strategic & customer-centric mindset, boasting more than 10 years of global experience as a team-player in B2B for both start-up environments & nano to mid-cap corporations. I aced a B.A degree, majoring with distinction, in Corporate Communications, Business Management & Public Relations. No challenge is too big for me. I resolve to make an impactful & positive difference within any organization & social setting. Known to go above and beyond in all that I do, I have a proven track record in strategically leading & motivating teams to desired outcomes, resulting in delighted clients & increased revenue.View the profile
Buy this talk
Buy this video
Our other topics
With ConferenceCast.tv, you get access to our library of the world's best conference talks.